Gelmon K - Search Results

1

Patterns of relapse in breast cancer: changes over time.

Yerushalmi R, Woods R, Kennecke H, Speers C, Knowling M, Gelmon K. Yerushalmi R, et al. Among authors: gelmon k. Breast Cancer Res Treat. 2010 Apr;120(3):753-9. doi: 10.1007/s10549-009-0510-2. Epub 2009 Aug 22. Breast Cancer Res Treat. 2010. PMID: 19701704

2

Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial.

Chia S, Clemons M, Martin LA, Rodgers A, Gelmon K, Pond GR, Panasci L. Chia S, et al. Among authors: gelmon k. J Clin Oncol. 2006 Jun 20;24(18):2773-8. doi: 10.1200/JCO.2005.03.8331. Epub 2006 May 8. J Clin Oncol. 2006. PMID: 16682726 Clinical Trial.

3

Molecular predictive factors in patients receiving trastuzumab-based chemotherapy for metastatic disease.

Robinson AG, Turbin D, Thomson T, Yorida E, Ellard S, Bajdik C, Huntsman D, Gelmon K. Robinson AG, et al. Among authors: gelmon k. Clin Breast Cancer. 2006 Aug;7(3):254-61. doi: 10.3816/CBC.2006.n.038. Clin Breast Cancer. 2006. PMID: 16942643

4

The role of capecitabine in first-line treatment for patients with metastatic breast cancer.

Gelmon K, Chan A, Harbeck N. Gelmon K, et al. Oncologist. 2006;11 Suppl 1:42-51. doi: 10.1634/theoncologist.11-90001-42. Oncologist. 2006. PMID: 16971739 Free article. Review.

5

Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.

Lohrisch C, Paltiel C, Gelmon K, Speers C, Taylor S, Barnett J, Olivotto IA. Lohrisch C, et al. Among authors: gelmon k. J Clin Oncol. 2006 Oct 20;24(30):4888-94. doi: 10.1200/JCO.2005.01.6089. Epub 2006 Oct 2. J Clin Oncol. 2006. PMID: 17015884

6

Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin.

Dragowska WH, Verreault M, Yapp DT, Warburton C, Edwards L, Ramsay EC, Huxham LA, Minchinton AI, Gelmon K, Bally MB. Dragowska WH, et al. Among authors: gelmon k. Breast Cancer Res Treat. 2007 Dec;106(3):319-31. doi: 10.1007/s10549-007-9502-2. Epub 2007 Mar 9. Breast Cancer Res Treat. 2007. PMID: 17347776

7

Prescribing extended adjuvant letrozole.

Gelmon K. Gelmon K. Breast. 2007 Oct;16(5):446-55. doi: 10.1016/j.breast.2007.04.002. Epub 2007 Jun 4. Breast. 2007. PMID: 17544670 Review.

8

The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines.

Dranitsaris G, Rayson D, Vincent M, Chang J, Gelmon K, Sandor D, Reardon G. Dranitsaris G, et al. Among authors: gelmon k. Breast Cancer Res Treat. 2008 Feb;107(3):443-50. doi: 10.1007/s10549-007-9803-5. Epub 2007 Nov 3. Breast Cancer Res Treat. 2008. PMID: 17978870

9

Chemotherapy for oestrogen-receptor-negative breast cancer.

Yerushalmi R, Gelmon K. Yerushalmi R, et al. Among authors: gelmon k. Lancet. 2008 Jan 5;371(9606):4-5. doi: 10.1016/S0140-6736(08)60043-4. Lancet. 2008. PMID: 18177755 No abstract available.

10

Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial.

Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JK, Lane K, Yasui Y, Segal RJ. Courneya KS, et al. Among authors: gelmon k. Cancer. 2008 Apr 15;112(8):1845-53. doi: 10.1002/cncr.23379. Cancer. 2008. PMID: 18306372 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters